Literature DB >> 18801939

Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset.

Ming-Tai Lin1, Shyh-Jye Chen, Yi-Lwun Ho, Kuo-Chin Huang, Chun-An Chen, Shuenn-Nan Chiu, Li-Chuan Sun, Wen-Jeng Lee, Hui-Chi Chen, Jou-Kou Wang, Mei-Hwan Wu.   

Abstract

BACKGROUND: Patients with a history of Kawasaki disease (KD), have been found to have pericoronary and myocardial fibrosis. Serum biomarkers of fibrosis may be sensitive indices for detection of these late cardiac complications in KD patients.
METHODS: We studied a cohort of 60 adolescents and young adults comprising 10 KD patients with persistent coronary artery lesions (CAL) occurring at a mean (SD) time of 14.5 (4.4) years after disease onset, 25 KD patients with no CAL after disease onset, and 25 healthy age-matched volunteers. We compared laboratory data from the patients and volunteers, including lipid profile, liver function, amino-terminal propeptide of type III procollagen (PIIINP), matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), and MMP-9:TIMP-1 ratios. Severity of CAL was determined on the basis of computed tomography determinations of the frequency of aneurysms and the extent of coronary stenosis/occlusion, thrombosis, and calcification.
RESULTS: Increased PIIINP and decreased MMP-9 and TIMP-1 concentrations and decreased MMP-9:TIMP-1 ratios were found not only in KD patients with persistent CAL but also in KD patients without CAL, although to a lesser extent in the latter group. In KD patients, the concentrations of PIIINP were positively associated with the severity of coronary stenosis/occlusion (r = 0.72, P = 0.011) and with the extent of coronary thrombus (r = 0.64, P = 0.014). The concentrations of high-sensitivity C-reactive protein, however, did not differ across groups.
CONCLUSIONS: Our results demonstrate alterations in extracellular matrix biomarkers in KD patients, suggesting enhanced collagen synthesis and ameliorated degradation in adolescents and young adults late after the onset of KD. We also observed an association between the concentrations of PIIINP and the extent of coronary stenosis/occlusion or thrombosis in KD patients, a finding that needs confirmation in further studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801939     DOI: 10.1373/clinchem.2008.105023

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Ring-calcification of giant coronary artery aneurysm of an 11-year-old child with history of kawasaki disease.

Authors:  Mehrdad Salamat; Muhammad Sher Khan
Journal:  Pediatr Cardiol       Date:  2009-11-21       Impact factor: 1.655

2.  First report on the lipid profile late after kawasaki disease in Iranian children.

Authors:  Seyyed-Naserredin Mostafavi; Elham Barzegar; Nayereh Siyah Manssori; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2014-07

Review 3.  Cardiac biomarkers in children with congenital heart disease.

Authors:  Masaya Sugimoto; Seiko Kuwata; Clara Kurishima; Jeong Hye Kim; Yoich Iwamoto; Hideaki Senzaki
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

4.  Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease.

Authors:  Lijian Xie; Renjian Wang; Min Huang; Yongwei Zhang; Jie Shen; Tingting Xiao
Journal:  Cardiovasc Ultrasound       Date:  2016-01-12       Impact factor: 2.062

5.  Myocardial fibrosis in patients with a history of Kawasaki disease.

Authors:  Susan M Dusenbery; Jane W Newburger; Steven D Colan; Kimberlee Gauvreau; Annette Baker; Andrew J Powell
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-18

6.  Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.

Authors:  Maja Stojanovic; Sanvila Raskovic; Vladimir Milivojevic; Rada Miskovic; Ivan Soldatovic; Sanja Stankovic; Ivan Rankovic; Marija Stankovic Stanojevic; Sanja Dragasevic; Miodrag Krstic; Andreas P Diamantopoulos
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.